https://telehealthglp1guide.comWhat a GLP-1 program actually costs, at every doseen-ushttps://telehealthglp1guide.com/guides/what-a-year-of-tirzepatide-costs/https://telehealthglp1guide.com/guides/what-a-year-of-tirzepatide-costs/The full-year arithmetic for compounded tirzepatide across every rankable US program, and the four things that move the number.2026-08-11https://telehealthglp1guide.com/guides/flat-vs-dose-tiered-pricing/https://telehealthglp1guide.com/guides/flat-vs-dose-tiered-pricing/Why two programs advertising the same price can cost hundreds apart over a titration year, with worked examples from the database.2026-08-11https://telehealthglp1guide.com/guides/verify-a-pharmacy/https://telehealthglp1guide.com/guides/verify-a-pharmacy/Six checks that establish who actually makes your compounded GLP-1, under what licence, with what inspection history.2026-08-11https://telehealthglp1guide.com/guides/start-price-vs-maintenance-price/https://telehealthglp1guide.com/guides/start-price-vs-maintenance-price/Why the advertised GLP-1 price and your third invoice differ, and how to read past a 'from' figure.2026-08-11https://telehealthglp1guide.com/guides/compounded-tirzepatide-vs-zepbound/https://telehealthglp1guide.com/guides/compounded-tirzepatide-vs-zepbound/The cash-price gap between compounded tirzepatide and the approved product, and what sits inside that gap.2026-08-11https://telehealthglp1guide.com/guides/compounded-tirzepatide-503a-lanes/https://telehealthglp1guide.com/guides/compounded-tirzepatide-503a-lanes/What changed when the shortages were resolved, what 503A compounding still permits, and how to read a program's lane.2026-08-11https://telehealthglp1guide.com/guides/what-a-year-of-semaglutide-costs/https://telehealthglp1guide.com/guides/what-a-year-of-semaglutide-costs/Full-year compounded semaglutide costs across every rankable US program, and why the field is tighter than tirzepatide's.2026-08-11https://telehealthglp1guide.com/guides/compounded-semaglutide-vs-wegovy/https://telehealthglp1guide.com/guides/compounded-semaglutide-vs-wegovy/The cash-price gap, what the trial evidence does and does not cover, and the salt-form question.2026-08-11https://telehealthglp1guide.com/guides/oral-and-sublingual-glp1/https://telehealthglp1guide.com/guides/oral-and-sublingual-glp1/What is actually being sold as needle-free GLP-1, why absorption is the open question, and why these are not price-ranked here.2026-08-11https://telehealthglp1guide.com/guides/semaglutide-dose-ladder-economics/https://telehealthglp1guide.com/guides/semaglutide-dose-ladder-economics/What sixteen weeks of titration costs on flat versus tiered programs, and why long-term framing changes the maths.2026-08-11https://telehealthglp1guide.com/guides/insurance-and-appeals/https://telehealthglp1guide.com/guides/insurance-and-appeals/How to establish whether your plan covers a GLP-1, and the prior authorisation and appeal sequence when it denies.2026-08-11https://telehealthglp1guide.com/guides/how-to-read-this-database/https://telehealthglp1guide.com/guides/how-to-read-this-database/What the five evidence statuses mean, why the gaps matter more than the numbers, and how to challenge a figure.2026-08-11https://telehealthglp1guide.com/guides/tirzepatide-dose-ladder-economics/https://telehealthglp1guide.com/guides/tirzepatide-dose-ladder-economics/What twenty weeks of tirzepatide titration costs on flat versus tiered programs, and the incentive problem tiering creates.2026-08-11https://telehealthglp1guide.com/guides/membership-fees/https://telehealthglp1guide.com/guides/membership-fees/Who charges a membership, why it behaves worse than a higher medication price, and when it is actually defensible.2026-08-11https://telehealthglp1guide.com/guides/prepaid-plans-and-risk/https://telehealthglp1guide.com/guides/prepaid-plans-and-risk/What twelve-month tirzepatide terms save, what you are betting on, and why refund policy and discount are one decision.2026-08-11https://telehealthglp1guide.com/guides/what-all-inclusive-should-mean/https://telehealthglp1guide.com/guides/what-all-inclusive-should-mean/The five separable components of a GLP-1 purchase, a four-question test, and which programs unbundle nothing.2026-08-11https://telehealthglp1guide.com/guides/switching-providers/https://telehealthglp1guide.com/guides/switching-providers/How to change tirzepatide providers without losing your titration position or your supply.2026-08-11https://telehealthglp1guide.com/guides/why-compounded-tirzepatide-costs-what-it-does/https://telehealthglp1guide.com/guides/why-compounded-tirzepatide-costs-what-it-does/The real cost structure behind compounded tirzepatide, how to read a price below the field floor, and what the brand premium buys.2026-08-11https://telehealthglp1guide.com/guides/glp1-price-war/https://telehealthglp1guide.com/guides/glp1-price-war/The same molecule at the same dose spans hundreds of dollars a month across US programs. The spread, what drives it, and how to use it.2026-08-11https://telehealthglp1guide.com/guides/if-your-provider-shuts-down/https://telehealthglp1guide.com/guides/if-your-provider-shuts-down/The plan to have ready before you need it: records, prepaid exposure, avoiding a gap, and choosing a replacement on disclosure.2026-08-11https://telehealthglp1guide.com/guides/stopping-glp1-weight-regain/https://telehealthglp1guide.com/guides/stopping-glp1-weight-regain/Trial evidence shows substantial regain after stopping, which makes the relevant cost an indefinite horizon rather than a year.2026-08-11https://telehealthglp1guide.com/blog/trumprx-glp1-price-deal/https://telehealthglp1guide.com/blog/trumprx-glp1-price-deal/Zepbound moves from over $1,080 to about $346 and Ozempic, Wegovy and Zepbound land near $350 on the federal platform. What it does to compounded pricing.2026-08-11https://telehealthglp1guide.com/blog/medicare-glp1-bridge/https://telehealthglp1guide.com/blog/medicare-glp1-bridge/The Medicare GLP-1 Bridge runs 1 July 2026 to 31 December 2027 with a maximum $50 monthly copay — below every cash price in our database.2026-08-11https://telehealthglp1guide.com/blog/fda-warning-letters-telehealth/https://telehealthglp1guide.com/blog/fda-warning-letters-telehealth/25 letters over allegedly false or misleading compounded GLP-1 claims — the four marketing patterns cited, and how to read a program's copy now.2026-08-11https://telehealthglp1guide.com/blog/fda-503b-bulks-decision/https://telehealthglp1guide.com/blog/fda-503b-bulks-decision/The comment period closed 30 July 2026 with no final decision. What was proposed, what is misreported, and what it means for what you pay.2026-08-11https://telehealthglp1guide.com/blog/novo-hims-lawsuit-glp1-litigation/https://telehealthglp1guide.com/blog/novo-hims-lawsuit-glp1-litigation/A manufacturer suing the telehealth layer directly, and a product-liability MDL at 3,928 cases. Two tracks, different implications.2026-08-11https://telehealthglp1guide.com/blog/research-grade-peptides/https://telehealthglp1guide.com/blog/research-grade-peptides/Connecticut's attorney general announced an overseas platform will cease selling research-grade GLP-1s into the US. What that label actually means.2026-08-11https://telehealthglp1guide.com/blog/glp1-insurance-coverage-2026/https://telehealthglp1guide.com/blog/glp1-insurance-coverage-2026/Commercial coverage is up from roughly 25% in 2024, 55% of large employers are taking the obesity rider, and sleep apnea and MASH open other doors.2026-08-11https://telehealthglp1guide.com/blog/foundayo-orforglipron-explained/https://telehealthglp1guide.com/blog/foundayo-orforglipron-explained/Approved April 2026 as the first oral non-peptide GLP-1 for weight management. Why a small molecule changes the economics, and the efficacy trade-off.2026-08-11https://telehealthglp1guide.com/blog/retatrutide-what-we-know/https://telehealthglp1guide.com/blog/retatrutide-what-we-know/Positive Phase 3 topline on 21 May 2026 with over 28% weight loss — and why anything sold as compounded retatrutide is not the trial drug.2026-08-11https://telehealthglp1guide.com/blog/cagrisema-explained/https://telehealthglp1guide.com/blog/cagrisema-explained/Roughly 23% weight loss from cagrilintide plus semaglutide, an FDA response expected in 2026, and what it does to compounded semaglutide.2026-08-11https://telehealthglp1guide.com/journal/evidence-ledger/https://telehealthglp1guide.com/journal/evidence-ledger/All 67 price records grouped by evidence status, with capture dates and sources, and what would upgrade each one.2026-08-11https://telehealthglp1guide.com/journal/price-changes/https://telehealthglp1guide.com/journal/price-changes/Promotional rates with published expiry dates, the standard rates behind them, and corrections to our own figures.2026-08-11https://telehealthglp1guide.com/journal/open-questions/https://telehealthglp1guide.com/journal/open-questions/The open questions in this GLP-1 price database: unpublished dose ladders, unnamed pharmacies, state coverage and unrankable programs.2026-08-11https://telehealthglp1guide.com/journal/dataset-versions/https://telehealthglp1guide.com/journal/dataset-versions/Every capture date in dataset v2026-08-11, what was captured on each, and how to reproduce the rankings.2026-08-11